81
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes

, , &
Pages 1381-1391 | Published online: 20 Aug 2015

References

  • SaadFGoorenLJThe role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2J Obes20112011110
  • FeldmanHALongcopeCDerbyCAAge trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging studyJ Clin Endocrinol Metab200287258959811836290
  • TajarAHuhtaniemiITO’NeillTWCharacteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)J Clin Endocrinol Metab20129751508151622419720
  • WuFCTajarABeynonJMIdentification of late-onset hypogonadism in middle-aged and elderly menN Engl J Med2010363212313520554979
  • LunenfeldBMskhalayaGKalinchenkoSTischovaTRecommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested updateAging Male201316414315024188520
  • TkaczyszynMNegaKŁopuszańskaMAndropausal syndrome in men with systolic heart failurePol Arch Med Wew20131234156169
  • American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201437suppl 1S81S9024357215
  • RheeSYWooJTThe prediabetic period: review of clinical aspectsDiabetes Metab J201135210711621738892
  • ChoNHWhitingDGuariguataLIDF Diabetes Atlas6th edBelgiumInternational Diabetes Federation20133949
  • DhindsaSPrabhakarSSethiMBandyopadhyayAChaudhuriADandonaPFrequent occurrence of hypogonadotropic hypogonadism in type 2 diabetesJ Clin Endocrinol Metab200489115462546815531498
  • KapoorDAldredHClarkSChannerKSJonesTHClinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposityDiabetes Care200730491191717392552
  • GavardJALustmanPJClouseREPrevalence of depression in adults with diabetes: an epidemiological evaluationDiabetes Care1993168116711788375247
  • RabijewskiMPapierskaLPiątkiewiczPLate-onset hypogonadism among old and middle-aged males with prediabetes in Polish populationAging Male2015181162125657079
  • CoronaGRastrelliGBalerciaGHormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal studyJ Sex Med2012961669168022489756
  • HoCHYuHJWangCYPrediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndromePLoS One201389e7417324069277
  • AthyrosGVGanotakisESElisafMMikhailidisDOThe prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsCurr Med Res Opin20052181157116416083523
  • ZungWWKA cross-cultural survey of symptoms in depressionAm J Psychiatry19691261161215798374
  • DaigIHeinemannLAKimSThe aging males’ symptoms (AMS) scale: review of its methodological characteristicsHealth Qual Life Outcomes20031778414675485
  • VermeulenAVerdonckLKaufmanJMA critical evaluation of simple methods for the estimation of free testosterone in serumJ Clin Endocrinol Metab199984103666367210523012
  • ColangeloLAOuyangPLiuKAssociation of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosisDiabetes Care20093261049105119289858
  • CorralesJJBurgoRMGarca-BerrocalBPartial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic controlMetabolism200453566667215131775
  • FukuiMTanakaMTodaHAndropausal symptoms in men with type 2 diabetesDiabet Med20122981036104222248017
  • ColaoADi SommaCCascellaTRelationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjectsEur J Endocrinol2008159438939718603571
  • KamedaWDaimonMOizumiTAssociation of decrease in serum dehydroepandrosterone sulfate levels with the progresstion to type 2 diabetes in men of a Japanese population: the Funagata StudyMetabolism200554566967615877298
  • CheungKKLukAOSoWYTestosterone level in men with type 2 diabetes mellitus and related metabolic effects: a review of current evidenceJ Diabetes Investig201562112123
  • ChandelADhindsaSTopiwalaSChaudhuriADandonaPTestosterone concentration in young patients with diabetesDiabetes Care200831102013201718650372
  • StanworthRDJonesTHTestosterone in obesity, metabolic syndrome and type 2 diabetesFront Horm Res200937749019011290
  • PitteloudNHardinMDwyerAAIncreasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in menJ Clin Endocrinol Metab20059052636264115713702
  • AndersonRJClouseREFredlandKELustmanPJThe prevalence of comorbid depression in adults with aiabetesDiabetes Care20012461069107811375373
  • de GrootMAndersonRFreedlandKEClouseRELustmanPJAssociation of depression and diabetes complications: a meta-analysisPsychosom Med200163461963011485116
  • LustmanPJAndersonRJFreedlandKEde GrootMCarneyRMClouseREDepression and poor glycemic control: a meta-analytic review of the literatureDiabetes Care200023793494210895843
  • ZitzmannMFaberSNieschlagEAssociation of specific symptoms and metabolic risks with serum testosterone in older menJ Clin Endocrinol Metab200691114335434316926258
  • Barrett-ConnorEVon MuhlenDGKritz-SilversteinDBioavailable testosterone and depressed mood in older men: the Rancho Bernardo StudyJ Clin Endocrinol Metab199984257357710022418
  • LejeuneHHuygheEDroupySHypoactive sexual desire and testosterone deficiency in menProg Urol201323962162823830256
  • JohnsonJMNachtigallLBSternTAThe effect of testosterone levels on mood in men: a reviewPsychosomatics201354650951424016385
  • BorstSEYarrowJFFernandezCCognitive effects of testosterone and finasteride administration in older hypogonadal menClin Interv Aging2014121327133325143719
  • ZarroufFAArtzSGriffithJSirbuCKommorMTestosterone and depression: systematic review and meta-analysisJ Psychiatr Pract200915428930519625884
  • SaukkonenTCederbergHJokelainenJLimited overlap between intermediate hyperglycemia as defined by A1C 5.7%–6.4%, impaired fasting glucose, and impaired glucose toleranceDiabetes Care201134102314231621816975